{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T19:48:30Z","timestamp":1791143310287,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1007\/s12325-013-0051-2","type":"journal-article","created":{"date-parts":[[2013,9,2]],"date-time":"2013-09-02T06:45:14Z","timestamp":1378104314000},"page":"748-762","source":"Crossref","is-referenced-by-count":31,"title":["A Review of the Impact of Pneumococcal Polysaccharide Conjugate Vaccine (7-valent) on Pneumococcal Meningitis"],"prefix":"10.1007","volume":"30","author":[{"given":"Myint","family":"Tin Tin Htar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harish","family":"Madhava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Balmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Christopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damianos","family":"Menegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,3]]},"reference":[{"issue":"11","key":"51_CR1","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1086\/587897","volume":"46","author":"CJ Tsai","year":"2008","unstructured":"Tsai CJ, Griffin MR, Nuorti JP, Grijalva CG. Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States. Clin Infect Dis. 2008;46(11):1664\u201372 (Epub 2008\/04\/25).","journal-title":"Clin Infect Dis"},{"issue":"9693","key":"51_CR2","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","volume":"374","author":"KL O\u2019Brien","year":"2009","unstructured":"O\u2019Brien KL, Wolfson LJ, Watt JP, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5\u00a0years: global estimates. Lancet. 2009;374(9693):893\u2013902 (Epub 2009\/09\/15).","journal-title":"Lancet"},{"issue":"4","key":"51_CR3","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1017\/S0950268806007199","volume":"135","author":"ED McIntosh","year":"2007","unstructured":"McIntosh ED, Fritzell B, Fletcher MA. Burden of paediatric invasive pneumococcal disease in Europe, 2005. Epidemiol Infect. 2007;135(4):644\u201356 (Epub 2006\/09\/09).","journal-title":"Epidemiol Infect"},{"issue":"1","key":"51_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1473-3099(09)70306-8","volume":"10","author":"KS Kim","year":"2010","unstructured":"Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis. 2010;10(1):32\u201342 (Epub 2010\/02\/05).","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"51_CR5","doi-asserted-by":"crossref","first-page":"e39150","DOI":"10.1371\/journal.pone.0039150","volume":"7","author":"AJ Hoek van","year":"2012","unstructured":"van Hoek AJ, Andrews N, Waight PA, George R, Miller E. Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes. PloS one. 2012;7(7):e39150 (Epub 2012\/07\/21).","journal-title":"PloS one"},{"issue":"11","key":"51_CR6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/000992280104001102","volume":"40","author":"HB Neuman","year":"2001","unstructured":"Neuman HB, Wald ER. Bacterial meningitis in childhood at the Children\u2019s Hospital of Pittsburgh: 1988\u20131998. Clin Pediatr (Phila). 2001;40(11):595\u2013600 (Epub 2002\/01\/05).","journal-title":"Clin Pediatr (Phila)"},{"issue":"Suppl 3","key":"51_CR7","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/S0929-693X(08)75491-5","volume":"15","author":"C Levy","year":"2008","unstructured":"Levy C, Bingen E, Aujard Y, et al. Surveillance network of bacterial meningitis in children, 7\u00a0years of survey in France. Arch Pediatr. 2008;15(Suppl 3):S99\u2013104 (Epub 2009\/03\/14. Observatoire national des meningites bacteriennes de l\u2019enfant en France : resultats de 7 annees d\u2019etude).","journal-title":"Arch Pediatr"},{"issue":"3","key":"51_CR8","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.pcl.2005.02.011","volume":"52","author":"S Chavez-Bueno","year":"2005","unstructured":"Chavez-Bueno S, McCracken GH Jr. Bacterial meningitis in children. Pediatr Clin North Am. 2005;52(3):795\u2013810 (vii. Epub 2005\/06\/01).","journal-title":"Pediatr Clin North Am"},{"issue":"2","key":"51_CR9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12325-013-0007-6","volume":"30","author":"TT Myint","year":"2013","unstructured":"Myint TT, Madhava H, Balmer P, et al. The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature review. Adv Ther. 2013;30(2):127\u201351 (Epub 2013\/02\/12).","journal-title":"Adv Ther"},{"key":"51_CR10","unstructured":"EUVac.Net. Pneumococcal vaccination (PCV) overview in European countries. 2012. http:\/\/www.euvac.net\/graphics\/euvac\/vaccination\/pcv.html . Accessed 24 Oct 2012."},{"issue":"30","key":"51_CR11","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.vaccine.2009.04.044","volume":"27","author":"P Rendi-Wagner","year":"2009","unstructured":"Rendi-Wagner P, Paulke-Korinek M, Kundi M, et al. National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases. Vaccine. 2009;27(30):3963\u20138 (Epub 2009\/04\/28).","journal-title":"Vaccine"},{"issue":"16","key":"51_CR12","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1016\/j.vaccine.2011.02.016","volume":"29","author":"G Hanquet","year":"2011","unstructured":"Hanquet G, Lernout T, Vergison A, et al. Impact of conjugate 7-valent vaccination in Belgium: addressing methodological challenges. Vaccine. 2011;29(16):2856\u201364 (Epub 2011\/02\/24).","journal-title":"Vaccine"},{"issue":"14","key":"51_CR13","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1016\/j.vaccine.2010.01.017","volume":"28","author":"ZB Harboe","year":"2010","unstructured":"Harboe ZB, Valentiner-Branth P, Benfield TL, et al. Early effectiveness of heptavalent conjugate pneumococcal vaccination on invasive pneumococcal disease after the introduction in the Danish Childhood Immunization Programme. Vaccine. 2010;28(14):2642\u20137 (Epub 2010\/01\/26).","journal-title":"Vaccine"},{"issue":"5","key":"51_CR14","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3201\/eid1605.091223","volume":"16","author":"GD Rodenburg","year":"2010","unstructured":"Rodenburg GD, de Greeff SC, Jansen AG, et al. Effects of pneumococcal conjugate vaccine 2\u00a0years after its introduction, the Netherlands. Emerg Infect Dis. 2010;16(5):816\u201323 (Epub 2010\/04\/23).","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"51_CR15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1086\/594125","volume":"48","author":"C Ardanuy","year":"2009","unstructured":"Ardanuy C, Tubau F, Pallares R, et al. Epidemiology of invasive pneumococcal disease among adult patients in Barcelona before and after pediatric 7-valent pneumococcal conjugate vaccine introduction, 1997-2007. Clin Infect Dis. 2009;48(1):57\u201364 (Epub 2008\/11\/28).","journal-title":"Clin Infect Dis"},{"issue":"5","key":"51_CR16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s10096-007-0294-4","volume":"26","author":"J Aristegui","year":"2007","unstructured":"Aristegui J, Bernaola E, Pocheville I, et al. Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccine. Eur J Clin Microbiol Infect Dis. 2007;26(5):303\u201310 (Epub 2007\/04\/26).","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"9","key":"51_CR17","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1469-0691.2006.1502_1.x","volume":"12","author":"E Calbo","year":"2006","unstructured":"Calbo E, Diaz A, Canadell E, et al. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect. 2006;12(9):867\u201372.","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"51_CR18","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1469-0691.2009.02904.x","volume":"15","author":"M Guevara","year":"2009","unstructured":"Guevara M, Barricarte A, Gil-Setas A, et al. Changing epidemiology of invasive pneumococcal disease following increased coverage with the heptavalent conjugate vaccine in Navarre, Spain. Clin Microbiol Infect. 2009;15(11):1013\u20139.","journal-title":"Clin Microbiol Infect"},{"key":"51_CR19","doi-asserted-by":"crossref","unstructured":"Lepoutre A, Varon E, Georges S, Gutmann L, Levy-Bruhl D. Impact of infant pneumococcal vaccination on invasive pneumococcal diseases in France, 2001\u20132006. Euro Surveill. 2008;13(35). pii:18962 (Epub 2008\/09\/03).","DOI":"10.2807\/ese.13.35.18962-en"},{"issue":"2","key":"51_CR20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1086\/524660","volume":"46","author":"C Munoz-Almagro","year":"2008","unstructured":"Munoz-Almagro C, Jordan I, Gene A, Latorre C. Garcia\u2013Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis. 2008;46(2):174\u201382 (Epub 2008\/01\/04).","journal-title":"Clin Infect Dis"},{"issue":"10","key":"51_CR21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","volume":"11","author":"E Miller","year":"2011","unstructured":"Miller E, Andrews NJ, Waight PA, Slack MP, George RC. Herd immunity and serotype replacement 4\u00a0years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis. 2011;11(10):760\u20138.","journal-title":"Lancet Infect Dis"},{"issue":"12","key":"51_CR22","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1086\/518149","volume":"44","author":"WC Albrich","year":"2007","unstructured":"Albrich WC, Baughman W, Schmotzer B, Farley MM. Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis. 2007;44(12):1569\u201376 (Epub 2007\/05\/23).","journal-title":"Clin Infect Dis"},{"issue":"18","key":"51_CR23","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa022823","volume":"348","author":"CG Whitney","year":"2003","unstructured":"Whitney CG, Farley MM, Hadler J, et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348(18):1737\u201346.","journal-title":"N Engl J Med"},{"issue":"1","key":"51_CR24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201(1):32\u201341 (Epub 2009\/12\/02).","journal-title":"J Infect Dis"},{"issue":"3","key":"51_CR25","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1056\/NEJMoa0800836","volume":"360","author":"HE Hsu","year":"2009","unstructured":"Hsu HE, Shutt KA, Moore MR, et al. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med. 2009;360(3):244\u201356 (Epub 2009\/01\/16).","journal-title":"N Engl J Med"},{"issue":"48\u201349","key":"51_CR26","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1016\/j.vaccine.2005.08.100","volume":"23","author":"TW Hennessy","year":"2005","unstructured":"Hennessy TW, Singleton RJ, Bulkow LR, et al. Impact of heptavalent pneumococcal conjugate vaccine on invasive disease, antimicrobial resistance and colonization in Alaska Natives: progress towards elimination of a health disparity. Vaccine. 2005;23(48\u201349):5464\u201373 (Epub 2005\/09\/29).","journal-title":"Vaccine"},{"issue":"48","key":"51_CR27","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1016\/j.vaccine.2012.09.019","volume":"30","author":"NJ Andrews","year":"2012","unstructured":"Andrews NJ, Waight PA, George RC, Slack MP, Miller E. Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales. Vaccine. 2012;30(48):6802\u20138 (Epub 2012\/09\/25).","journal-title":"Vaccine"},{"issue":"5","key":"51_CR28","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1093\/cid\/cis971","volume":"56","author":"RD Muhammad","year":"2013","unstructured":"Muhammad RD, Oza-Frank R, Zell E, et al. Epidemiology of invasive pneumococcal disease among high-risk adults since the introduction of pneumococcal conjugate vaccine for children. Clin Infect Dis. 2013;56(5):e59\u201367 (Epub 2012\/11\/17).","journal-title":"Clin Infect Dis"},{"issue":"2","key":"51_CR29","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/INF.0b013e3181f4cf69","volume":"30","author":"C Levy","year":"2011","unstructured":"Levy C, Varon E, Bingen E, et al. Pneumococcal meningitis in French children before and after the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2011;30(2):168\u201370 (Epub 2011\/02\/08).","journal-title":"Pediatr Infect Dis J"},{"issue":"3","key":"51_CR30","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1128\/JCM.01917-12","volume":"51","author":"B Pichon","year":"2013","unstructured":"Pichon B, Ladhani SN, Slack MP, et al. Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales. J Clin Microbiol. 2013;51(3):820\u20137 (Epub 2012\/12\/28).","journal-title":"J Clin Microbiol"},{"issue":"1","key":"51_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/01.inf.0000148891.32134.36","volume":"24","author":"K Hsu","year":"2005","unstructured":"Hsu K, Pelton S, Karumuri S, Heisey-Grove D, Klein J. Population-based surveillance for childhood invasive pneumococcal disease in the era of conjugate vaccine. Pediatr Infect Dis J. 2005;24(1):17\u201323.","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"51_CR32","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10096-011-1241-y","volume":"30","author":"R Prymula","year":"2011","unstructured":"Prymula R, Chlibek R, Ivaskeviciene I, et al. Paediatric pneumococcal disease in Central Europe. Eur J Clin Microbiol Infect Dis. 2011;30(11):1311\u201320 (Epub 2011\/06\/15).","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"51_CR33","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1007\/s00431-002-1066-x","volume":"161","author":"W Hausdorff","year":"2002","unstructured":"Hausdorff W. Invasive pneumococcal disease in children: geographic and temporal variations in incidence and serotype distribution. Eur J Pediatr. 2002;161(2):S135\u20139.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"51_CR34","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1086\/313609","volume":"30","author":"WP Hausdorff","year":"2000","unstructured":"Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis. 2000;30(1):122\u201340 (Epub 2000\/01\/05).","journal-title":"Clin Infect Dis"},{"issue":"1","key":"51_CR35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1086\/313608","volume":"30","author":"WP Hausdorff","year":"2000","unstructured":"Hausdorff WP, Bryant J, Paradiso PR, Siber GR. Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis. 2000;30(1):100\u201321 (Epub 2000\/01\/05).","journal-title":"Clin Infect Dis"},{"issue":"1","key":"51_CR36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1695-4033(02)77779-5","volume":"56","author":"J Aristegui Fernandez de","year":"2002","unstructured":"de Aristegui Fernandez J, Corretger Rauet JM, Garcia Martin F, et al. Pneumococcal disease and its prevention. The heptavalent pneumococcal conjugate vaccine (La enfermedad neumococica y su prevencion. Vacuna neumococica conjugada heptavalente). An Esp Pediatr. 2002;56(1):79\u201390 (Epub 2002\/01\/17).","journal-title":"An Esp Pediatr"},{"issue":"11","key":"51_CR37","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1111\/j.1651-2227.2010.01914.x","volume":"99","author":"C Alexandre","year":"2010","unstructured":"Alexandre C, Dubos F, Courouble C, et al. Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement. Acta Paediatr. 2010;99(11):1686\u201390 (Epub 2010\/07\/16).","journal-title":"Acta Paediatr"},{"issue":"11","key":"51_CR38","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1097\/INF.0b013e31817bd2dc","volume":"27","author":"J Casado-Flores","year":"2008","unstructured":"Casado-Flores J, Rodrigo C, Aristegui J, Martinon JM, Fenoll A, Mendez C. Decline in pneumococcal meningitis in Spain after introduction of the heptavalent pneumococcal conjugate vaccine. Pediatr Infect Dis J. 2008;27(11):1020\u20132 (Epub 2008\/10\/11).","journal-title":"Pediatr Infect Dis J"},{"issue":"11","key":"51_CR39","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/adc.2007.119891","volume":"92","author":"F Dubos","year":"2007","unstructured":"Dubos F, Marechal I, Husson MO, et al. Decline in pneumococcal meningitis after the introduction of the heptavalent-pneumococcal conjugate vaccine in northern France. Arch Dis Child. 2007;92(11):1009\u201312 (Epub 2007\/07\/13).","journal-title":"Arch Dis Child"},{"issue":"5","key":"51_CR40","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eimc.2008.09.010","volume":"27","author":"L Salleras","year":"2009","unstructured":"Salleras L, Dominguez A, Ciruela P, Izquierdo C, Borras E, Grupo de Trabajo del Sistema de Notificacion Microbiologica de C. Impact of 7-valent pneumococcal conjugate vaccination in a population with low to intermediate vaccination levels. Enferm Infecc Microbiol Clin. 2009;27(5):275\u20137 (Epub 2009\/04\/24. Impacto de la vacuna neumococica conjugada heptavalente en una poblacion con valores bajos-intermedios de vacunacion).","journal-title":"Enferm Infecc Microbiol Clin"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-013-0051-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,22]],"date-time":"2019-07-22T23:15:15Z","timestamp":1563837315000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-013-0051-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1007\/s12325-013-0051-2","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}